Vitamin D: Drug of the future. A new therapeutic approach

Archives of Gerontology and Geriatrics

Volumn 54, Issue 1, 2012, Pages 222-227

  Gueli, N ^a   Verrusio, W ^a   Linguanti, A ^a   Di Maio, F ^a   Martinez, A ^a   Marigliano, B ^a   Cacciafesta, M ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Pleiotropic effects of vitamin D; Supplementation therapy; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCITRIOL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; ROSUVASTATIN; VITAMIN D; VITAMIN D RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTHRALGIA; ARTICLE; ASTHMA; BONE MINERALIZATION; BREAST CANCER; CALCIUM ABSORPTION; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COLON ADENOCARCINOMA; COLON CANCER; COMA; CONSTIPATION; DEPRESSION; DIARRHEA; DISORIENTATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INTERMITTENT THERAPY; DRUG MECHANISM; DRUG MEGADOSE; DRUG RESEARCH; DRUG SYNTHESIS; FALLING; FRACTURE; HEART PROTECTION; HUMAN; HYPERCALCEMIA; HYPERCHOLESTEROLEMIA; IMMUNOMODULATION; INFECTION PREVENTION; INFECTION RISK; KIDNEY INJURY; LOW DRUG DOSE; LUNG CANCER; MOOD DISORDER; MUSCLE CRAMP; NAUSEA; NEOPLASM; NEUROPROTECTION; NONHUMAN; OSTEOMALACIA; OSTEOPOROSIS; PANCREAS CANCER; PATHOLOGIC FRACTURE; PRIORITY JOURNAL; PROSTATE CANCER; RENAL PROTECTION; RISK FACTOR; RISK REDUCTION; SINGLE DRUG DOSE; SUNLIGHT; UNSPECIFIED SIDE EFFECT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; VOMITING;

HUMANS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 80054939307     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2011.03.001     Document Type: Article

References (44)

1. Autier P., Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 2007, 167:1730-1737.
2. Baeke F., Van Etten E., Gysemans C., Overbergh L., Mathieu C. Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities. Mol. Aspects Med. 2008, 29:376-387.
3. Boonen S., Singer A.J. Osteoporosis management: impact of fracture type on cost and quality of life in patients at risk for fracture I. Curr. Med. Res. Opin. 2008, 24:1781-1788.
4. Cannell J.J., Vieth R., Umhau J.C., Holick M.F., Grant W.B., Madronich S., Garland C.F., Giovannucci E. Epidemic influenza and vitamin D. Epidemiol. Infect. 2006, 134:1129-1140.
5. Cheung C.Y., Poon L.L., Lau A.S., Luk W., Lau Y.L., Shortridge K.F., Gordon S., Guan Y., Peiris J.S. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 2002, 360:1831-1837.
6. Chung I., Han G., Seshadri M., Gillard B.M., Yu W.D., Foster B.A., Trump D.L., Johnson C.S. Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo. Cancer Res. 2009, 69:967-975.
7. Clifford R.L., Knox A.J. Vitamin D-a new treatment for airway remodelling in asthma?. Br. J. Pharmacol. 2009, 158:1426-1428.
8. Cutolo M., Otsa K., Uprus M., Paolino S., Seriolo B. Vitamin D in rheumatoid arthritis. Autoimmun. Rev. 2007, 7:59-64.
9. Deeb K.K., Trump D.L., Johnson C.S. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat. Rev. Cancer 2007, 7:684-700.
10. Dobnig H., Pilz S., Scharnagl H., Renner W., Seelhorst U., Wellnitz B., Kinkeldei J., Boehm B.O., Weihrauch G., Maerz W. Independent association of low serum 25-hydroxyvitamin D and 1,25 dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 2008, 168:1340-1349.
11. Evatt M.L., Delong M.R., Khazai N., Rosen A., Triche S., Tangpricha V. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch. Neurol. 2008, 65:1348-1352.
12. Forman J.P., Curhan G.C., Taylor E.N. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 2008, 52:828-832.
13. Garland C.F., Garland F.C., Gorham E.D., Lipkin M., Newmark H., Mohr S.B., Holick M.F. The role of vitamin D in cancer prevention. Am. J. Public Health 2006, 96:252-261.
14. Ginde A.A., Mansbach J.M., Camargo C.A. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 2009, 169:384-390.
15. 3. FASEB J. 2005, 19:1067-1077.
16. Grant W.B. Ecological studies of solar UV-B radiation and cancer mortality rates. Recent Res. Cancer Res. 2003, 164:371-377.
17. Hathcock J.N., Shao A., Vieth R., Heaney R. Risk assessment for vitamin D. Am. J. Clin. Nutr. 2007, 85:6-18.
18. Hewison M. Vitamin D and the intracrinology of innate immunity. Mol. Cell. Endocrinol. 2010, 321:103-111.
19. Hewison M., Zehnder D., Chakraverty R., Adams J.S. Vitamin D and barrier function: a novel role for extrarenal 1 alpha-hydroxylase. Mol. Cell. Endocrinol. 2004, 215:31-38.
20. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357:266-281.
21. Hoogendijk W.J., Lips P., Dik M.G., Deeg D.J., Beekman A.T., Penninx B.W. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch. Gen. Psychiatry 2008, 65:508-512.
22. Horváth H.C., Lakatos P., Kósa J.P., Bácsi K., Borka K., Bises G., Nittke T., Hershberger P.A., Speer G., Kállay E. The candidate oncogene CYP24A1: a potential biomarker for colorectal tumorigenesis. J. Histochem. Cytochem. 2010, 58:277-285.
23. Hughes D.A., Norton R. Vitamin D and respiratory health. Clin. Exp. Immunol. 2009, 158:20-25.
24. Janssens W., Bouillon R., Claes B., Carremans C., Lehouck A., Buysschaert I., Coolen J., Mathieu C., Decramer M., Lambrechts D. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010, 65:215-220.
25. Jenab M., Bueno-de-Mesquita H.B., Ferrari P., Van Duijnhoven F.J., Norat T., Pischon T., Jansen E.H., Slimani N., Byrnes G., Rinaldi S., Tjønneland A., Olsen A., Overvad K., Boutron-Ruault M.C., Clavel-Chapelon F., Morois S., Kaaks R., Linseisen J., Boeing H., Bergmann M.M., Trichopoulou A., Misirli G., Trichopoulos D., Berrino F., Vineis P., Panico S., Palli D., Tumino R., Ros M.M., Van Gils C.H., Peeters P.H., Brustad M., Lund E., Tormo M.J., Ardanaz E., Rodríguez L., Sánchez M.J., Dorronsoro M., Gonzalez C.A., Hallmans G., Palmqvist R., Roddam A., Key T.J., Khaw K.T., Autier P., Hainaut P., Riboli E. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. Br. Med. J. 2010, 340:b5500.
26. Kocián J., Brunová J. Diabetic osteopathies. 3. The effect of diabetic complications on bone mineralization. Vnitr. Lek. 1989, 35:890-898. (in Czech).
27. Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.R., Heaney R.P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 2007, 85:1586-1591.
28. 3 pathway in healthy and diseased skin: facts, contradictions and hypotheses. Exp. Dermatol. 2009, 18:97-108.
29. Mehta S., Hunter D.J., Mugusi F.M., Spiegelman D., Manji K.P., Giovannucci E.L., Hertzmark E., Msamanga G.I., Fawzi W.W. Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania. J. Infect. Dis. 2009, 200:1022-1030.
30. Michos E.D., Melamed M.L. Vitamin D and cardiovascular disease risk. Curr. Opin. Clin. Nutr. Metab. Care 2008, 11:7-12.
31. Miller G.J. Vitamin D and prostate cancer: biologic interactions and clinical potentials. Cancer Metast. Rev. 1998-1999, 17:353-360.
32. Morris H.A. Vitamin D: a hormone for all seasons-how much is enough?. Clin. Biochem. Rev. 2005, 26:21-32.
33. Naves-Díaz M., Alvarez-Hernández D., Passlick-Deetjen J., Guinsburg A., Marelli C., Rodriguez-Puyol D., Cannata-Andía J.B. Oral active vitamin D is associated with improved survival in hemodialysis patients. Kidney Int. 2008, 74:1070-1078.
34. Petta S., Cammà C., Scazzone C., Tripodo C., Di Marco V., Bono A., Cabibi D., Licata G., Porcasi R., Marchesini G., Craxí A. Low vitamin D serum level is related to severe fibrosis and low responsiveness to Interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010, 51:1158-1167.
35. Pilz S., März W., Wellnitz B., Seelhorst U., Fahrleitner-Pammer A., Dimai H.P., Boehm B.O., Dobnig H. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J. Clin. Endocrinol. Metab. 2008, 93:3927-3935.
36. Santos Arrontes D., García González J.I., Martín Muñoz M.P., Castro Pita M., Mañas Pelillo A., Paniagua Andrés P. Will the climate change affect the mortality from prostate cancer?. Arch. Esp. Urol. 2007, 60:119-123. (in Spanish).
37. Spina C.S., Ton L., Yao M., Maehr H., Wolfe M.M., Uskokovic M., Adorini L., Holick M.F. Selective vitamin D receptor modulators and their effects on colorectal tumor growth. J. Steroid Biochem. Mol. Biol. 2007, 103:757-762.
38. Stolzenberg-Solomon R.Z., Vieth R., Azad A., Pietinen P., Taylor P.R., Virtamo J., Albanes D. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res. 2006, 66:10213-10219.
39. Torkko K.C., Van Bokhoven A., Mai P., Beuten J., Balic I., Byers T.E., Hokanson J.E., Norris J.M., Barón A.E., Lucia M.S., Thompson I.M., Leach R.J. VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non Hispanic white and Hispanic white men. Clin. Cancer Res. 2008, 14:3223-3229.
40. Wactawski-Wende J., Kotchen J.M., Anderson G.L., Assaf A.R., Brunner R.L., O'Sullivan M.J., Margolis K.L., Ockene J.K., Phillips L., Pottern L., Prentice R.L., Robbins J., Rohan T.E., Sarto G.E., Sharma S., Stefanick M.L., Van Horn L., Wallace R.B., Whitlock E., Bassford T., Beresford S.A., Black H.R., Bonds D.E., Brzyski R.G., Caan B., Chlebowski R.T., Cochrane B., Garland C., Gass M., Hays J., Heiss G., Hendrix S.L., Howard B.V., Hsia J., Hubbell F.A., Jackson R.D., Johnson K.C., Judd H., Kooperberg C.L., Kuller L.H., LaCroix A.Z., Lane D.S., Langer R.D., Lasser N.L., Lewis C.E., Limacher M.C., Manson J.E. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med. 2006, 354:684-696. Women's Health Initiative Investigators.
41. Wang L., Manson J.E., Song Y., Sesso H.D. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann. Intern. Med. 2010, 152:315-323.
42. Weir M.R. Is activated vitamin D supplementation renoprotective?. Hypertension 2008, 52:211-212.
43. Wu K., Feskanich D., Fuchs C.S., Willett W.C., Hollis B.W., Giovannucci E.L. A nested case control study of plasma 25-hydroxyvitamin D concentration and risk of colorectal cancer. J. Natl. Cancer Inst. 2007, 99:1120-1129.
44. Yavuz B., Ertugrul D.T., Cil H., Ata N., Akin K.O., Yalcin A.A., Kucukazman M., Dal K., Hokkaomeroglu M.S., Yavuz B.B., Tutal E. Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins?. Cardiovasc. Drugs Ther. 2009, 23:295-299.